martes, 14 de mayo de 2019

Unlock the power of immuno-oncology for your research

abcam
 
 
CTLA-4
 
Further your immuno-oncology research with our monoclonal CTLA-4 antibody suitable for use in IHC and flow cytometry.
 
Take a look
 
 
 
ICOS
 
Discover the link between ICOS and CTLA4 as immunotherapy targets using our ICOS recombinant monoclonal antibody validated for use in flow cytometry.
 
See the data
 
SLAMF6
 
SLAMF6 is the latest immune-modulator to be investigated as a therapeutic target. Get ahead of the game with our recombinant monoclonal SLAMF6 antibody.
 
Find out more

No hay comentarios:

Publicar un comentario